Bio-Techne, Refeyn Partner on Workflow for Bispecific Antibody, Biosimilar Characterization
This week, Bio-Techne, a provider of life science tools, reagents, and diagnostic product, and Refeyn, a pioneer in mass photometry technology, announced the launch of an integrated workflow for characterizing charge and size variants...
A Billion-Dollar Deal, Trial Trouble, Biohub Updates, and Vaccine Research News
In this week’s episode, we start with news that Fulcrum Therapeutics is scrapping its lead pipeline program for sickle cell disease following concerns from the FDA about the drug’s risks and benefits. Also on...
Brain-Targeted Drug Discovery Barriers Drive Deep Science Ventures and Medicines Discovery Catapult Deal
Deep Science Ventures (DSV) and Medicine Discovery Catapult (MDC) agreed to collaborate to address challenges in delivering medicines into the brain.
One of medicine’s greatest challenges is ensuring that treatments reach the precise area of...
Immune Cell Phenotyping: Cell Surface Architecture Informs Disease Biology
Register Now
Erdinc Sezgin, PhD Senior LecturerKarolinska Institutet View Bio
Panelist ...
Lilly, Ascidian Launch Up-to-$1.9B RNA Exon Editor Collaboration Targeting Inherited Kidney Diseases
Eli Lilly has expanded its genetic medicines pipeline and capabilities, agreeing to partner with Ascidian Therapeutics to develop RNA exon editors intended to treat inherited kidney diseases, through a collaboration that could generate more...
Cross-Reactive T Cells Could Point to Broad Vaccines or Treatments for Measles, Nipah Virus
T cells are some of the immune system’s most important fighters. They can stop tumor growth and fight off severe infections. Scientists at La Jolla Institute for Immunology (LJI) have now reported a study...
Turning the Patent Cliff into a Bioplant Opportunity
The 2030 patent cliff may either decimate revenue streams or provide an opportunity for innovation that can transform the biopharmaceutical industry. As it stands today, some 200 biopharmaceuticals are scheduled to go off patent...
New SMArT platform improves safety of CRISPR gene editing
A team of researchers led by Luigi Naldini at the San Raffaele Telethon Institute for Gene Therapy (SR-Tiget) has developed a new strategy to significantly improve the precision and safety of CRISPR-Cas9 gene editing...
Building a better biosensor polymer
Credit: © 2021 KAUST; Xavier Pita
A new organic (carbon-based) semiconducting material has been developed that outperforms existing options for building the next generation of biosensors. An...
AI-Powered Pan-Cancer Map Reveals Tertiary Lymphoid Structures
Researchers at The University of Texas MD Anderson Cancer Center have developed a spatial atlas of specialized immune structures known as tertiary lymphoid structures (TLSs), across multiple cancer types, revealing how key features vary...
